These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16940805)

  • 1. Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.
    Brunstein F; Hoving S; aan de Wiel-Ambagtsheer G; de Bruijn EA; Guetens G; Eggermont AM; ten Hagen TL
    Cancer Immunol Immunother; 2007 Apr; 56(4):573-80. PubMed ID: 16896966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics.
    Wei H; Li Z; Qian K; Du W; Ju L; Shan D; Yu M; Fang Y; Zhang Y; Xiao Y; Wang G; Wang X
    Pharmacogenomics J; 2024 Aug; 24(5):24. PubMed ID: 39112450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review.
    Kong C; Chen X
    Int J Nanomedicine; 2022; 17():6427-6446. PubMed ID: 36540374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.
    Amin M; Seynhaeve ALB; Sharifi M; Falahati M; Ten Hagen TLM
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy.
    Zheng J; Wang X; Yu J; Zhan Z; Guo Z
    Front Oncol; 2022; 12():997665. PubMed ID: 36226059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Concentrations of Chemerin, α-Defensin 1, and TNF-α as Potential Biomarkers in the Early Diagnosis of Colorectal Cancer.
    Waniczek D; Świętochowska E; Śnietura M; Kiczmer P; Lorenc Z; Muc-Wierzgoń M
    Metabolites; 2022 Jul; 12(8):. PubMed ID: 36005576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.
    Kurago Z; Loveless J
    Front Oral Health; 2021; 2():739499. PubMed ID: 35048056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer.
    Lee J; Beatty GL
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.
    Mercogliano MF; Bruni S; Mauro F; Elizalde PV; Schillaci R
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unleashing endogenous TNF-alpha as a cancer immunotherapeutic.
    Josephs SF; Ichim TE; Prince SM; Kesari S; Marincola FM; Escobedo AR; Jafri A
    J Transl Med; 2018 Aug; 16(1):242. PubMed ID: 30170620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.
    Menssen HD; Harnack U; Erben U; Neri D; Hirsch B; Dürkop H
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):499-507. PubMed ID: 29327244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature.
    Podleska LE; Funk K; Umutlu L; Grabellus F; Taeger G; de Groot H
    Br J Cancer; 2015 Aug; 113(4):645-52. PubMed ID: 26171939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy.
    Schaffran T; Jiang N; Bergmann M; Küstermann E; Süss R; Schubert R; Wagner FM; Awad D; Gabel D
    Int J Nanomedicine; 2014; 9():3583-90. PubMed ID: 25114527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.
    Spitaleri G; Berardi R; Pierantoni C; De Pas T; Noberasco C; Libbra C; González-Iglesias R; Giovannoni L; Tasciotti A; Neri D; Menssen HD; de Braud F
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):447-55. PubMed ID: 23160853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery.
    Brunstein F; Rens J; van Tiel ST; Eggermont AM; ten Hagen TL
    Br J Cancer; 2006 Dec; 95(12):1663-9. PubMed ID: 17106443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.
    Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL
    Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.
    Hoving S; Brunstein F; aan de Wiel-Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
    Cancer Res; 2005 May; 65(10):4300-8. PubMed ID: 15899822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.